[EN] PHARMACEUTICAL COMPOUNDS AND DERIVATIVES<br/>[FR] COMPOSÉS PHARMACEUTIQUES ET DÉRIVÉS
申请人:PFIZER PROD INC
公开号:WO2009027785A2
公开(公告)日:2009-03-05
Pharmaceutical compounds according to Formula I and derivatives, pharmaceutical compositions containing such compounds and the use of such compounds to elevate certain plasma lipid levels, including high density lipoprotein-cholesterol and to lower certain other plasma lipid levels, such as LDL-cholesterol and triglycerides and accordingly to treat diseases which are exacerbated by low levels of HDL cholesterol and/or high levels of LDL-cholesterol and triglycerides, such as atherosclerosis and cardiovascular diseases in some mammals, including humans. Formula (I) or a pharmaceutically acceptable salt of said compound; wherein Formula (II) M and J are each independently CH2 or a bond wherein at least one of M and J are CH2.
Silver comes into play: Henry reaction and domino cycloisomerisation sequence catalysed by [Ag(<scp>i</scp>)(Pc-L)] complexes
The Ag(i) complexes of pyridine-containing ligands with an active pendant arm are new catalysts for an old reaction: the nitroaldol condensation. When the substrates are 2-alkynylarylaldehydes, a smart cascade cycloisomerisation process can occur.